SynthesisMedicine2021

Comparison of atezolizumab, durvalumab, pembrolizumab, and nivolumab as first-line treatment in patients with extensive-stage small cell lung cancer: A systematic review and network meta-analysis.

Jianxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.